Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Filings indexed 1,018 across all filing types
Latest filing 2022-01-07 Director's Dealing
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2022-01-07 English
PRIMARY DOCUMENT
Director's Dealing
2022-01-07 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on leadership changes, specifically the departure of the President and CEO, appointment of new Presidents for business units, and related compensation changes. There are no financial statements or detailed financial performance data included. The document is not an annual or quarterly report, earnings release, or any other financial report type. It is clearly an announcement of changes in the company's board or senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (9866 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2022-01-06 English
PRIMARY DOCUMENT
Director's Dealing
2022-01-03 English
PRIMARY DOCUMENT
Director's Dealing
2021-12-23 English
PRIMARY DOCUMENT
Director's Dealing
2021-11-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.